SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-003129
Filing Date
2020-04-30
Accepted
2020-04-30 16:07:14
Documents
2
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_043020.htm 8-K 11707
2 PRESS RELEASE exh_991.htm EX-99.1 36195
  Complete submission text file 0001171843-20-003129.txt   49039
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 20835678
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences